Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

10.1K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
10.1K
Sex-linked Disorders01:43

Sex-linked Disorders

111.6K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
111.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.5K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep brain stimulation for the treatment of patients with dystonia: advances towards network-based personalised care.

The Lancet. Neurology·2026
Same author

Novel advanced patient-derived <i>in vitro</i> models of pediatric movement disorders to develop personalized therapeutic strategies.

Frontiers in neurology·2026
Same author

Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich's ataxia models.

Cell reports. Medicine·2026
Same author

Unprocessed U1 snRNAs as a biomarker of INTS11- and BRAT1-related neurodevelopmental disorders.

Genome medicine·2026
Same author

Expanding the phenotypic spectrum associated with ZIC1 variants: A neurodevelopmental disorder with and without craniosynostosis.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Longitudinal Phenotypic Trajectories in GNAO1-Related Disorders: Defining Disease Progression and Clinical Profiles.

Annals of neurology·2026

Related Experiment Video

Updated: Apr 6, 2026

Author Spotlight: Unveiling Mitochondrial Contact Sites and Architectural Insights
07:55

Author Spotlight: Unveiling Mitochondrial Contact Sites and Architectural Insights

Published on: June 16, 2023

2.3K

Benign Hereditary Chorea: An Update.

Kathryn J Peall1, Manju A Kurian2

  • 1MRC Centre for Neuropsychiatric Genetics and Genomics, University of Cardiff, Cardiff, UK.

Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|July 22, 2015
PubMed
Summary

Benign hereditary chorea (BHC) is a rare genetic movement disorder. This review details its clinical features, genetic causes, and multisystem developmental abnormalities, aiding diagnosis and treatment.

Keywords:
Benign Hereditary ChoreaBrain-Lung-Thyroid disorderNKX2.1 mutations

More Related Videos

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.8K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

21.0K

Related Experiment Videos

Last Updated: Apr 6, 2026

Author Spotlight: Unveiling Mitochondrial Contact Sites and Architectural Insights
07:55

Author Spotlight: Unveiling Mitochondrial Contact Sites and Architectural Insights

Published on: June 16, 2023

2.3K
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.8K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

21.0K

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Benign hereditary chorea (BHC) is a childhood-onset hyperkinetic movement disorder.
  • It is linked to NKX2.1 gene mutations and the brain-lung-thyroid syndrome.
  • Classical BHC typically shows minimal motor progression into adulthood.

Purpose of the Study:

  • To review clinical findings in classical BHC.
  • To discuss atypical features, non-motor symptoms, and BHC as a developmental disorder.
  • To explore therapeutic efficacy in pediatric and adult BHC cohorts.

Main Methods:

  • Literature review of clinical findings.
  • Analysis of genetic basis (NKX2.1 mutations).
  • Discussion of developmental aspects and therapeutic outcomes.

Main Results:

  • BHC presents with chorea but can include non-choreiform movements.
  • Associated non-motor symptoms include cognitive and psychiatric issues.
  • Evidence suggests BHC involves impaired neural migration and multisystem abnormalities.

Conclusions:

  • Expanding the understanding of the BHC spectrum is crucial.
  • Improved diagnosis through genetic testing and clinical trials is needed.
  • Targeted therapies for BHC require further investigation.